Combination of Redox-Active Ligand and Lewis Acid for Dioxygen Reduction with π-Bound Molybdenum−Quinonoid Complexes by Henthorn, Justin T. et al.
	   	   S1 
Combination of Redox-Active Ligand and Lewis Acid for Dioxygen Reduction with 
π-Bound Molybdenum-Quinonoid Complexes 
Justin T. Henthorn, Sibo Lin and Theodor Agapie* 
Division of Chemistry and Chemical Engineering, California Institute of Techonology, Pasadena, CA 
91125 
 
I. Experimental Details  
General Considerations S4 
Synthesis of 2,3-dimethoxyphenylene-1,4-bis(pinacolato)boronic ester S5 
Synthesis of 1,4-bis(2-bromophenyl)-2,3-dimethoxybenzene S6 
Synthesis of 1,4-bis(2-bromophenyl)-2,3-dihydroxybenzene (1Br) S6 
Synthesis of 1,4-bis(2-bromophenyl)-2,3-di(methoxymethylether)benzene S7 
Synthesis of 1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol (1a) S7 
Synthesis of dimethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol)silane (1b) S8	  
Synthesis of diethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol)silane (1c) S8	  
Synthesis of diisopropyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol)silane (1d) S9	  
Synthesis of 4-(trifluoromethyl)phenyl-(1,4-bis(2-(diisopropylphosphino)phenyl)- 
2,3-catechol)borane (1e) S9 
Synthesis of 1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-dimethoxybenzene (1f) S10 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol]tricarbonylmolybdenum(0) (2a) S11 
Synthesis of [dimethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2b) S12 
Synthesis of [diethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2c) S13 
Synthesis of [diisopropyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2d) S14 
Synthesis of [4-(trifluoromethyl)phenyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)borane]tricarbonylmolybdenum(0) (2e) S14 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
dimethoxybenzene]tricarbonylmolybdenum(0) (2f) S15 
Synthesis of [tetramethyl-1,3-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)disiloxane]tricarbonylmolybdenum(0) (2h) S16 
Synthesis of [tetraethyl-1,3-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)disiloxane]tricarbonylmolybdenum(0) (2i) S16 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-quinone]dicarbonylmolybdenum(0) (3) S17 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
dimethoxybenzene]dicarbonylmolybdenum(II) trifluoromethanesulfonate ([52+][OTf-]2) S18	  
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
methylsemiquinonate]dicarbonylmolybdenum(II) trifluoromethanesulfonate ([6+][OTf-]) S19 
Synthesis of bis(1,3-dimethylcyclopentadienyl)iron(II) (Me4Fc) S19 
Control Reactions of 1Br, 2f, and 2g with O2 S20 
Reactions of 2b, 2c, 2d, 2e, 2f + B(C6F5)3 , 2g + B(C6F5)3, 2g + catechol, and 
       Me4Fc + catechol with O2 S21 
Reactions of 2a and 3 with H2O2 S25 
Quantification of O2 consumed and CO released in conversion of 2a to 3 S25 
 
II. Nuclear Magnetic Resonance Spectra  
Figure S1. 1H NMR spectrum of 1a in CDCl3 at 25 °C S27 
Figure S2. 13C{1H} NMR spectrum of 1a in CDCl3 at 25 °C S27 
Figure S3. 31P{1H} NMR spectrum of 1a in CDCl3 at 25 °C S27 
Figure S4. 1H NMR spectrum of 1b in CDCl3 at 25 °C S28 
Figure S5. 13C{1H} NMR spectrum of 1b in CDCl3 at 25 °C S28 
Figure S6. 31P{1H} NMR spectrum of 1b in CDCl3 at 25 °C S28 
Figure S7. 1H NMR spectrum of 1c in CDCl3 at 25 °C S29 
Figure S8. 13C{1H} NMR spectrum of 1c in CDCl3 at 25 °C S29 
	   	   S2 
Figure S9. 31P{1H} NMR spectrum of 1c in CDCl3 at 25 °C S29 
Figure S10. 1H NMR spectrum of 1d in CDCl3 at 25 °C S30 
Figure S11. 13C{1H} NMR spectrum of 1d in CDCl3 at 25 °C S30 
Figure S12. 31P{1H} NMR spectrum of 1d in CDCl3 at 25 °C S30 
Figure S13. 1H NMR spectrum of 1e in C6D6 at 25 °C S31 
Figure S14. 13C{1H} NMR spectrum of 1e in C6D6 at 25 °C S31 
Figure S15. 31P{1H} NMR spectrum of 1e in C6D6 at 25 °C S31 
Figure S16. 19F NMR spectrum of 1e in C6D6 at 25 °C S32 
Figure S17. 1H NMR spectrum of 1f in CDCl3 at 25 °C S32 
Figure S18. 13C{1H} NMR spectrum of 1f in CDCl3 at 25 °C S32 
Figure S19. 31P{1H} NMR spectrum of 1f in CDCl3 at 25 °C S33 
Figure S20. 1H NMR spectrum of 2a in C6D6 at 25 °C S33 
Figure S21. 13C{1H} NMR spectrum of 2a in C6D6 at 75 °C S33 
Figure S22. 31P{1H} NMR spectrum of 2a in C6D6 at 25 °C S34 
Figure S23. 1H NMR spectrum of 2b in C6D6 at 25 °C S34 
Figure S24. 13C{1H} NMR spectrum of 2b in C6D6 at 25 °C S34 
Figure S25. 31P{1H} NMR spectrum of 2b in C6D6 at 25 °C S35 
Figure S26. 1H NMR spectrum of 2c in C6D6 at 25 °C S35 
Figure S27. 13C{1H} NMR spectrum of 2c in C6D6 at 25 °C S35 
Figure S28. 31P{1H} NMR spectrum of 2c in C6D6 at 25 °C S36 
Figure S29. 1H NMR spectrum of 2d in C6D6 at 25 °C S36 
Figure S30. 13C{1H} NMR spectrum of 2d in C6D6 at 25 °C S36 
Figure S31. 31P{1H} NMR spectrum of 2d in C6D6 at 25 °C S37 
Figure S32. 1H NMR spectrum of 2e in C6D6 at 25 °C S37 
Figure S33. 13C{1H} NMR spectrum of 2e in C6D6 at 25 °C S37 
Figure S34. 19F NMR spectrum of 2e in C6D6 at 25 °C S38 
Figure S35. 31P{1H} NMR spectrum of 2a in C6D6 at 25 °C S38 
Figure S36. 1H NMR spectrum of 2f in C6D6 at 25 °C S38 
Figure S37. 13C{1H} NMR spectrum of 2f in C6D6 at 25 °C S39 
Figure S38. 31P{1H} NMR spectrum of 2f in C6D6 at 25 °C S39 
Figure S39. 1H NMR spectrum of 2h in C6D6 at 25 °C S39 
Figure S40. 13C{1H} NMR spectrum of 2h in C6D6 at 25 °C S40 
Figure S41. 31P{1H} NMR spectrum of 2h in C6D6 at 25 °C S40 
Figure S42. 1H NMR spectrum of 2i in C6D6 at 25 °C S40 
Figure S43. 13C{1H} NMR spectrum of 2i in C6D6 at 25 °C S41 
Figure S44. 31P{1H} NMR spectrum of 2i in C6D6 at 25 °C S41 
Figure S45. 1H NMR spectrum of 3 in CD3CN at 25 °C S41 
Figure S46. 13C{1H} NMR spectrum of 3 in CD3CN at 25 °C S42 
Figure S47. 31P{1H} NMR spectrum of 3 in CD3CN at 25 °C S42 
Figure S48. 1H NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C S42 
Figure S49. 13C{1H} NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C S43 
Figure S50. 19F NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C S43 
Figure S51. 31P{1H} NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C S44 
Figure S52. 1H NMR spectrum of [62+][OTf-] in CD3CN at 25 °C S44 
Figure S53. 13C{1H} NMR spectrum of [62+][OTf-] in CD3CN at 25 °C S44 
Figure S54. 19F NMR spectrum of [62+][OTf-] in CD3CN at 25 °C S44 
Figure S55. 31P{1H} NMR spectrum of [62+][OTf-] in CD3CN at 25 °C S45 
Figure S56. 1H NMR spectrum of Me4Fc in C6D6 at 25 °C S45 
Figure S57. 13C{1H} NMR spectrum of Me4Fc in C6D6 at 25 °C S45 
Figure S58. 1H NMR spectrum of 1Bra under 1 atm O2 in CD2Cl2 at 25 °C S46 
Figure S59. 1H and 31P{1H} NMR spectra of 2g under 1 atm O2 in C6D6 at 25 °C S46 
Figure S60. 1H and 31P{1H} NMR spectra of 2f under 1 atm O2 in CD2Cl2 at 25 °C S47 
Figure S61. 1H and 31P{1H} NMR spectra of 2a under 1 atm O2 in CD2Cl2 at 25 °C S47 
Figure S62. 1H and 31P{1H} NMR spectra of 2b under 1 atm O2 in CD2Cl2 at 25 °C S48 
Figure S63. 1H and 31P{1H} NMR spectra of 2c under 1 atm O2 in CD2Cl2 at 25 °C S48 
Figure S64. 1H and 31P{1H} NMR spectra of 2d under 1 atm O2 in CD2Cl2 at 25 °C S49 
	   	   S3 
Figure S65. 1H, 19F, and 31P{1H} NMR spectra of 2e under 1 atm O2 in CD2Cl2 at 25 °C S49 
Figure S66. 1H, 19F, and 31P{1H} NMR spectra of 3 and (ArFBO)3 in CD2Cl2 at 25 °C S50 
Figure S67. 1H, 19F, and 31P{1H} NMR spectra of 2f and B(C6F5)3 under 1 atm O2 in CD2Cl2  
at 25 °C S50 
Figure S68. 1H, 19F, and 31P{1H} NMR spectra of 2g and B(C6F5)3 under 1 atm O2 in CD2Cl2  
at 25 °C S51 
Figure S69. 1H and 31P{1H} NMR spectra of 2g and catechol under 1 atm O2 in CD2Cl2 at 25 °C S51 
Figure S70. 1H NMR spectra of Me4Fc and catechol under 1 atm O2 in CD2Cl2 at 25 °C S52 
 
 
 
 
III. Ultraviolet-Visible Spectroscopy 
Figure S71. UV-vis monitoring of reaction of 2f and B(C6F5)3 with O2 in DCM S53 
Figure S72. UV-vis monitoring of reaction of 2f with Ag(OTf) in THF S53 
 
 
IV. Cyclic Voltammetry  
Figure S73. Cyclic voltammograms of 2b, 2d, 2e, and 2f in THF S54 
 
V. Crystallographic Information  
Refinement Details S55 
Table 1. Crystal and Refinement data for 2a, 2b, 3, and [4+]2[{(F5C6)3B}2O22-] S56 
Figure S74. Structural drawing of 2a S57 
Figure S75. Structural drawing of 2b S57 
Figure S76. Structural drawing of 3 S58 
Figure S77. Structural drawing of [4+]2[{(F5C6)3B}2O22-] S58 
 
VI. References S59  
	   	   S4 
I. Experimental Details 
 
General considerations:  
Unless indicated otherwise, reactions performed under inert atmosphere were 
carried out in oven-dried glassware in a glovebox under a nitrogen atmosphere purified 
by circulation through RCI-DRI 13X-0408 Molecular Seives 13X, 4x8 Mesh Beads and 
BASF PuriStar® Catalyst R3-11G, 5x3 mm (Research Catalysts, Inc.). Solvents for all 
reactions were purified by Grubbs’ method.1 C6D6 was purchased from Cambridge 
Isotope Laboratories and vacuum distilled from sodium benzophenone ketyl. CD3CN, 
CD2Cl2, and CDCl3 were also purchased from Cambridge Isotope Laboratories and 
distilled from CaH2 prior to use. Alumina and Celite were activated by heating under 
vacuum at 200 °C for 24 hours. 1H, 19F, and 31P NMR spectra were recorded on Varian 
Mercury 300 MHz spectrometers at ambient temperature, unless denoted otherwise. 13C 
NMR spectra were recorded on a Varian INOVA-500 MHz spectrometer. 1H and 13C 
NMR chemical shifts are reported with respect to internal solvent: 7.16 ppm and 128.06 
ppm for C6D6, 1.94 ppm and 118.26 for CD3CN, 5.32 ppm and 53.84 ppm for CD2Cl2, 
and 7.26 ppm and 77.16 ppm for CDCl3, respectively. 19F and 31P NMR chemical shifts 
are reported with respect to an external standard of C6F6 (-164.9 ppm) and 85% H3PO4 
(0.0 ppm).  
Powder and thin film ATR-IR measurements were obtained by placing a powder 
or drop of solution of the complex on the surface of a Bruker APLHA ATR-IR 
spectrometer probe and allowing the solent to evaporate (Platinum Sampling Module, 
diamond, OPUS software package) at 2 cm–1 resolution. Solution IR spectra were 
recorded on a Thermo-Fisher Scientific Nicolet 6700 FTIR spectrometer using a CaF2 
plate solution cell. Fast atom bombardment-mass spectrometry (FAB-MS) analysis was 
performed with a JEOL JMS-600H high resolution mass spectrometer. Gas 
chromatography-mass spectrometry (GC-MS) analysis was performed upon filtering the 
sample through a plug of silica gel. Electrochemical measurements were recorded with a 
Pine Instrument Company AFCBP1 bipotentiostat using the AfterMath software package. 
Cyclic voltammograms were recorded on ca.  2 mM solutions of the relevant complex in 
the glovebox at 20 °C with an auxiliary Pt-coil electrode, a Ag/Ag+ reference electrode 
(0.01 M AgNO3, 0.1 M [nBu4N+][PF6-] in MeCN), and a 3.0 mm glassy carbon electrode 
disc (BASI). The electrolyte solution was 0.1 M [nBu4N+][PF6-] in THF. All reported 
values are referenced to an internal ferrocene/ferrocenium couple. Elemental analysis was 
conducted by Robertson Microlit Labs (Ledgewood, NJ). 
Unless otherwise noted all chemical reagents were purchased from commercial 
sources and used without further purification. Pinacol, 2-bromoiodobenzene, HNpic2 
(HNpic2 = di(2-picolyl)amine), and para-trifluoromethylphenylboronic acid were 
purchased from Alfa Aesar. Veratrole and TMEDA were purchased from Alfa Aesar and 
distilled from CaH2 prior to use. B(OMe)3 was purchased from Alfa Aesar and distilled 
from sodium prior to use. Chlorodiisopropylphosphine and Cu(MeCN)4OTf were 
purchased from Sigma Aldrich. Me2SiCl2, Et2SiCl2, iPr2SiCl2, and (ClMe2Si)2 were 
purchased from Sigma Aldrich and distilled from CaH2 prior to use. (ClEt2Si)2O was 
prepared by hydrolysis of Et2SiCl2 followed by fractional distillation. Assignments of 
NMR spectra are given corresponding to the following numbering scheme: 
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Synthesis of 2,3-dimethoxyphenylene-1,4-bis(pinacolato)boronic ester 
 
 Adapted from the literature.2 On the Schlenk line, veratrole (10.0 mL, 78.5 mmol) 
and TMEDA (20.0 mL, 133 mmol) were added via syringe under a counter-flow of N2 to 
a 1000 mL Schlenk bomb charged with Et2O (500 mL) and a large stir bar and fitted with 
a rubber septum. The bomb was cooled toca. 4 °C using an ice bath, and under a counter-
flow of N2 nBuLi (100 mL, 2.5 M, 250 mmol) was added via Teflon cannula transfer. 
The ice bath was removed, the bomb was sealed with a screw-in Teflon stopper and 
heated to 40 °C (CAUTION: Always use a blast shield and all necessary personal 
protective equipment when heating/manipulating pyrophorics in a sealed vessel.) for 4 
hours with vigorous stirring (Note: large amounts of precipitate form during this stage, 
and if adequate stirring is not maintained the final yield will be significantly diminished). 
The reaction was removed from heat and once again cooled to ca. 4 °C using an ice bath 
and the Teflon stopper replaced with a rubber septum. B(OMe)3 (29.0 mL, 260 mmol) 
was then added via syringe under counterflow of N2 with vigorous stirring. After 
complete addition, the bomb was once again sealed with the screw-in Teflon stopper, and 
the reaction allowed to warm to room temperature over the course of 12 hours with 
stirring. The bomb was again cooled to ca. 4 °C using an ice bath, opened to air, and the 
mixture quenched with the slow addition of HCl (6 M, 500 mL, 3 mol). All further 
manipulations were performed in air. Upon complete addition of HCl, the mixture was 
transferred to a 2L separatory funnel and the layers separated. The aqueous layer was 
washed with Et2O (2 x 200 mL), and the combined organic layers were dried over 
MgSO4, filtered, and concentrated via rotary evaporation. The residue was combined with 
pinacol (19 g, 160 mmol) and toluene (50 mL) in a 500 mL round bottom flask charged 
with a stir bar and equipped with a Dean-Stark trap. The mixture was then refluxed for 4 
hours with stirring. After cooling to room temperature, all volatiles were removed by 
rotary evaporation and the residue was recrystallized from hot hexanes (ca. 200 mL) at -
30 °C to afford approximately 10 g of the desired product as off-white 
powder/microcrystalline solid. Concentration of the filtrate followed by recrystallization 
from pentane can afford approximately another 5 g of desired product. Total isolated 
yield is 15.449 g (50.5%). The obtained product displayed a 1H NMR spectrum matching 
that previously reported in literature.2 1H NMR (300 MHz, d6-acetone), δ(ppm): 7.31 (s, 
2H, Ar-CH), 3.80 (s, 6H, OCH3), 1.34 (s, 24H, C(CH3)2). 
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MeO OMe MeO OMe
BB
O
OO
O
i) 3 eq. n-BuLi/TMEDA
     Et2O, 40 °C
ii) 3 eq. B(OMe)3
iii) HCl
iv) 2 eq. pinacol
    toluene, reflux
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Synthesis of 1,4-bis(2-bromophenyl)-2,3-dimethoxybenzene 
 
Suzuki coupling conditions were adapted from a previously published procedure.3 2,3-
dimethoxyphenylene-1,4-bis(pinacolato)boronic ester (15.4993 g, 39.7 mmol), K2CO3 
(26 g, 190 mmol), toluene (340 mL), H2O (185 mL), EtOH (185 mL) were combined in a 
1000 mL Schlenk bomb with screw-in Teflon stopper. The mixture was degassed by 
three freeze-pump-thaw cycles, and 2-bromoiodobenzene (10.7 mL, 83.3 mmol) and 
Pd(PPh3)4 (1.744 g, 1.51 mmol) were added under a counter-flow of N2. The mixture was 
again degassed by a freeze-pump-thaw cycle, and the Schlenk tube was placed in an oil 
bath and heated to 80°C. After stirring for 12 h, the mixture was allowed to cool to room 
temperature, and further manipulations were performed in air. The volatiles removed via 
rotary evaporation. H2O (250 mL) and DCM (250 mL) were added and the mixture 
transferred to a 1L separatory funnel with vigorous mixing. The layers were separated 
and the aqueous layer washed with DCM (2 x 100 mL). The combined organic fractions 
were dried over MgSO4, filtered, and concentrated via rotary evaporation. The residue 
was dissolved in hot MeOH (100 mL), filtered, and cooled to -30 °C in a freezer. After 
12 hours the resulting white precipitate was collected on a glass frit, rinsing with minimal 
cold MeOH and dried under vacuum to afford the desired product (10.3468 g, 58.1%). 1H 
NMR (300 MHz, CDCl3), δ(ppm): 7.70 (d, 8.0 Hz, 2 H, Ar-CH), 7.39 (d, 5.5 Hz, 4 H, 
Ar-CH), 7.25 (m, 2 H, Ar-CH), 6.99 (s, 2 H, Ar-C1H), 3.70 (s, 6 H, OCH3). 13C NMR (75 
MHz, CDCl3), δ(ppm): 150.58 (s, Ar-CH), 139.44 (s, Ar-CH), 135.88 (s, Ar-CH), 132.74 
(s, Ar-CH), 131.56 (s, Ar-CH), 129.07 (s, Ar-CH), 127.10 (s, Ar-CH), 125.33 (s, Ar-CH), 
123.92 (s, Ar-CH), 60.97 (s, OCH3). MS (m/z): calcd, 447.9496 [M]+; found, 447.9483 
(FAB+, [M]+). 
 
Synthesis of 1,4-bis(2-bromophenyl)-2,3-dihydroxybenzene (1Br) 
 
In a Schlenk flask under N2 counterflow, 1,4-di(2-bromophenyl)-2,3-dimethoxybenzene 
(8.4322 g, 18.8 mmol) was dissolved in DCM (50 mL) with stirring. The flask was fitted 
with a septum and chilled to -78 °C in a dry ice/acetone bath. BBr3 (4.5 mL neat, 1 
mmol) was added to the flask drop-wise via syringe over 5 min. The reaction was 
allowed to warm to room temperature over 12 h. After cooling with an ice/water bath, the 
reaction was then quenched by slow dropwise addition of H2O until bubbling ceased. 
Further manipulations performed in air. The reaction mixture was further diluted with 
H2O (50 mL). The mixture was transferred to a separatory funnel, mixed well, and the 
layers separated. The aqueous layer was washed with DCM (2 x 25 mL). The combined 
organics were dried with MgSO4, filtered, and concentrated via rotary evaporation to 
yield the desired product as a tan powder (7.389 g, 93.5%). 1H NMR (300 MHz, CDCl3), 
Br Br
MeO OMe
MeO OMe
BB
O
OO
O
2.1 eq.
K2CO3
5 mol% Pd(PPh3)4
toluene/EtOH/H2O
75 °C 12h
Br
I
BrBr
OMeMeO
2.5 eq. BBr3
DCM, -78 °C
BrBr
OHHO
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δ(ppm): 7.75 (d, 2 H, Ar-CH), 7.46 (s, 2 H, Ar-CH), 7.44 (s, 2 H, Ar-CH), 7.34-7.27 (m, 
2 H, Ar-CH), 6.84 (s, 2 H, Ar-C1H), 5.34 (br, 2 H, OH).13C{1H} NMR (126 MHz, 
CDCl3), δ(ppm): 140.9 (s, Ar-CH), 138.1 (s, Ar-CH), 133.2 (s, Ar-CH), 132.1 (s, Ar-
CH), 129.7 (s, Ar-CH), 127.9 (s, Ar-CH), 127.7 (s, Ar-CH), 124.0 (s, Ar-CH), 121.9 (s, 
Ar-CH). MS (m/z): calcd, 419.9184 [M]+; found, 419.9180 (FAB+, [M]+). 
 
 
Synthesis of 1,4-bis(2-bromophenyl)-2,3-di(methoxymethylether)benzene 
 
A Schlenk flask was charged with 1,4-di(2-bromophenyl)-2,3-dihydroxybenzene (6.0973 
g, 14.5 mmol) dissolved in PhMe (100 mL). Under N2 counter-flow, a 2.1 M solution of 
chloromethyl methyl ether in toluene (21.0 mL, 44.1 mmol)4 was added to the stirred 
reaction mixture, followed by N,N-diisopropylethylamine (7.8 mL, 43.7 mmol). The 
reaction was allowed to stir for 12 hours at room temperature under N2. The volatiles 
were removed under rotary evaporation, and further manipulations were performed in air. 
The residue was dissolved in H2O (150 mL) and DCM (150 mL) and transferred to a 
separatory funnel. The layers were separated and the aqueous layer washed with DCM (2 
x 50 mL). The combined organic extracts were dried with MgSO4, filtered and 
concentrated under rotary evaporation to yield the desired product as a white powder 
(6.9031 g, 93.6%). 1H NMR (300 MHz, CDCl3), δ(ppm): 7.68 (d, 2 H, Ar-CH), 7.51-7.34 
(m, 4 H, Ar-CH), 7.25-7.19 (m, 2 H, Ar-CH), 7.07 (s, 2 H, Ar-C1H), 5.01-4.85 (br, 4 H, 
CH2OCH3), 2.93 (s, 6 H, CH2OCH3). 13C{1H} NMR (75 MHz, CDCl3), δ(ppm): 147.8 (s, 
Ar-CH), 139.4 (s, Ar-CH), 136.6 (s, Ar-CH), 132.6 (s, Ar-CH), 132.3 (s, Ar-CH), 129.0 
(s, Ar-CH), 127.0 (s, Ar-CH), 126.0 (s, Ar-CH), 124.2 (s, Ar-CH), 99.2 (s, Ar-CH), 56.7 
(s, Ar-CH). MS (m/z): calcd, 507.9708 [M]+; found, 507.9713 (FAB+, [M]+). 
 
Synthesis of 1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol (1a) 
 
 
A Schlenk tube was charged with 1,4-di(2-bromophenyl)-2,3-
di(methoxymethylether)benzene (6.9031 g, 13.6 mmol), THF (60 mL), and a stir bar. The 
reaction mixture was cooled to -78 °C with the use of a dry ice/acetone bath. Under a 
counter-flow of N2, a 1.7 M solution of tBuLi (33.0 mL, 56.1 mmol) in pentanes was 
added via syringe drop-wise. A light yellow color appeared in seconds, and as the 
reaction was allowed to stir for 30 minutes at -78 °C, a pale orange color evolved. After 
stirring for 1 hour at -78 °C, chlorodiisopropylphosphine (4.60 mL, 28.6 mmol) was 
added to the reaction mixture via syringe under a counter-flow of N2, inducing a light 
3 eq. NEtiPr2
3 eq. CH3OCH2Cl
PhMe, 25 °C
BrBr
OHHO
BrBr
OCH2OCH3H3COH2CO
(iPr)2PP(iPr)2
OHHO
BrBr
OCH2OCH3H3COH2CO
i) 4.1 eq. tBuLi
    THF, -78 °C
ii) 2.1 eq. ClPiPr2
   -78 °C to rt
iii) xs HCl, MeOH
	   	   S8 
yellow color. After stirring for 1 hour at -78 °C, the reaction was removed from the dry 
ice/acetone bath and allowed to warm to room temperature. After stirring for 2 hours at 
room temperature the volatiles were removed under reduced pressure. To the residue was 
added degassed MeOH (60 mL) and HCl (12 M, 10 mL). The mixture was then heated to 
60 °C for 4 hours. After cooling to room temperature, the volatiles were again removed 
under reduced pressure. All further manipulations were performed under an N2 
atmosphere in a water-tolerant nitrogen-filled glove box. The residue was treated with 
DCM (100 mL) and saturated aqueous K2CO3 (100 mL) and transferred to a separatory 
funnel with vigorous mixing. The layers were separated and the organics washed with 
saturated aqueous NH4Cl (100 mL). The layers were again separated and the aqueous 
layer washed with DCM (2 x 50 mL). The combined organics were dried with MgSO4, 
filtered, and concentrated under vacuum to afford an off-white powder. Trituration with 
MeOH (25 mL) afforded a white precipitate that was collected on a glass frit. The solid 
was washed with Et2O (25 mL) and MeCN (25 mL), and then dried under vacuum to 
yield the desired product in 81.3% yield (5.4627 g). 1H NMR (300 MHz, CDCl3), 
δ(ppm): 7.57 – 7.50 (m, 2 H, Ar-CH), 7.45 – 7.36 (m, 6 H, Ar-CH), 6.80 (s, 2 H, Ar-
C1H), 6.56, (br, 2 H, Ar-C3OH), 2.24 (br, 2 H, PCH(CH3)2), 2.02 (br, 2 H, PCH(CH3) 2), 
1.20 – 0.80 (br, 24 H, PCH(CH3)2). 31P{1H} (121 MHz, CDCl3), δ(ppm): 3.06 (br), 2.17 
(br), -1.56 (s), -29.16 (s). 13C{1H} (126 MHz, CDCl3) d: 146.25 (d), 141.00 (s), 134.00 
(d), 131.99 (s), 131.67 (s), 130.02 (s), 128.90 (s), 126.97 (s), 123.95 (s), 25.04 (br), 22.47 
(br), 20.00 (br), 18.97 (br). MS (m/z): calcd, 493.2425 [M-H]+; found, 493.2438 (FAB+, 
[M-H]+). 
 
Synthesis of dimethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol)silane 
(1b) 
 
Diphosphine 1a (2.5003 g, 5.06 mmol), Me2SiCl2 (0.835 g, 6.47 mmol), and Et3N 
(1.2033 g, 11.9 mmol) were combined with PhMe (20 mL) in a Schlenk bomb charged 
with a stir bar and a screw-in Teflon stopper. The bomb was removed from the glove box 
and heated to 100 °C in an oil bath for 12 hours generating a white precipitate. After 
cooling to room temperature, the bomb was taken back into the glove box and the white 
precipitate filtered on celite, washing with additional PhMe. The filtrate was then 
concentrated in vacuo to yield the desired compound 1b as a white powder in 97.5% 
yield (2.7152 g).  1H NMR (300 MHz, C6D6), δ(ppm): 7.40 (m, 4 H, Ar-CH), 7.14 (m, 4 
H, Ar-CH), 6.94 (s, 2 H, Ar-C1H), 1.90 (m, 4 H, PCH(CH3)2), 0.99 (m, 24 H, 
PCH(CH3)2), 0.17 (s, 6 H, SiCH3). 31P{1H} (121 MHz, C6D6), δ(ppm): -1.24 (s). 13C{1H} 
NMR (126 MHz, C6D6), δ(ppm): 146.55 (s), 146.31 (s), 145.87 (s), 136.32 (d), 132.53 
(d), 131.23 (d), 128.66 (s), 126.89 (s), 123.45 (d), 24.66 (br), 20.68 (s), 20.52 (s), 19.73 
(br), -0.02 (s, SiCH3). Compound hydrolyzed under FAB-MS conditions, only mass 
consistent with 1a observed. 
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Synthesis of diethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol)silane 
(1c) 
 
 
 
Compound 1c was prepared analogously to above using diphosphine 1a (0.1555 g, 0.314 
mmol), Et2SiCl2 (0.0715 g, 0.455 mmol), and Et3N (0.1031 g, 1.02 mmol) in PhMe (10 
mL). The desired compound 1c was isolated as a white powder in 98.5% yield (0.1793 
g).  1H NMR (300 MHz, CDCl3), δ(ppm): 7.55 (m, 2 H, Ar-CH), 7.36 (m, 6 H, Ar-CH), 
6.75 (s, 2 H, Ar-C1H), 2.03 (m, 4 H, PCH(CH3)2), 0.97 (m, 4 H, PCH(CH3)2 and 
SiCH2CH3). 31P{1H} (121 MHz, CDCl3), δ(ppm): -2.06 (br), -2.73 (br).  13C{1H} NMR 
(126 MHz, CDCl3), δ(ppm): 146.15 (s), 145.85 (s), 145.61 (s), 135.77 (d), 132.41 (s), 
131.14 (s), 123.22 (s), 126.73 (d), 123.15 (s), 24.36 (d, PCH(CH3)2), 20.29 (s, 
PCH(CH3)2), 20.14 (s, PCH(CH3)2), 19.67 (d, PCH(CH3)2), 6.72 (s, SiCH2CH3), 5.49 (s, 
SiCH2CH3). MS (m/z): calcd, 579.2977 [M+H]+; found, 579.2980 (FAB+, [M+H]+). 
 
 
Synthesis of diisopropyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane (1d) 
 
 
 
Compound 1d was prepared analogously to above using diphosphine 1a (0.1518 g, 0.307 
mmol), iPr2SiCl2 (0.0976 g, 0.527 mmol), and Et3N (0.0942 g, 0.931 mmol) in PhMe (10 
mL). The desired compound 1d was isolated as a white powder in 96.7% yield (0.1799 
g).  1H NMR (300 MHz, CDCl3), δ(ppm): 7.58 (m, 2 H, Ar-CH), 7.38 (m, 6 H, Ar-CH), 
6.76 (s, 2 H, Ar-C1H), 2.03 (m, 4 H, PCH(CH3)2), 1.05 (m, 42 H, PCH(CH3)2 and 
SiCH(CH3)2). 31P{1H} (121 MHz, CDCl3), δ(ppm): -2.61 (br), -2.98 (br).  13C{1H} NMR 
(126 MHz, CDCl3), δ(ppm): 146.62 (s), 145.89 (s), 145.66 (s), 135.67 (d), 132.39 (s), 
131.42 (s), 128.05 (s), 126.57 (m), 123.32 (s), 24.46 (d, PCH(CH3)2), 20.31 (s, 
PCH(CH3)2), 20.17 (s, PCH(CH3)2), 19.78 (d, PCH(CH3)2), 16.04 (s, SiCH(CH3)2), 13.02 
(s, SiCH(CH3)2). MS (m/z): calcd, 607.3290 [M+H]+; found, 607.3290 (FAB+, [M+H]+). 
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Synthesis of 4-(trifluoromethyl)phenyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-
2,3-catechol)borane (1e) 
 
 
 
In the wet glove box under an atmosphere of N2, 1a (1.53 g, 3.09 mmol) and 
p(F3C)C6H4B(OH)2 (0.5876 g, 3.09 mmol), and MgSO4 (0.4 g, 3.3 mmol) were combined 
in a Schlenk tube with m-xylenes (10 mL). The reaction was heated to 120 °C for 2.5 
hours. The volatiles were removed under vacuum, the residue washed with Et2O (10 mL), 
and the product extracted with C6H6 (15 mL), filtered through Celite, and concentrated 
under vacuum to yield 0.9 g (44.8%) of the desired product as an off-white solid. 1H 
NMR (300 MHz, C6D6), δ(ppm): 7.80 (m, 2 H, Ar-CH), 7.52 (m, 2 H, Ar-CH), 7.37 (m, 
2 H, Ar-CH), 7.24 (m, 2 H, Ar-CH), 7.20 (s, 2 H, Ar-C1H), 1.92 (m, 4 H, PCH(CH3)2), 
0.98 (m, 24 H, PCH(CH3)2). 31P{1H} (121 MHz, C6D6), δ(ppm): -1.54 (s). 19F NMR (282 
MHz, C6D6 , 25 °C), δ(ppm): -61.52 (s).  13C{1H} NMR (126 MHz, C6D6), δ(ppm): 
146.01 (s), 145.02 (s), 144.78 (s), 136.57 (s), 136.39 (s), 135.78 (s), 133.74 (q, CF3), 
132.79 (s), 131.12 (s), 128.88 (s), 127.62 (s), 125.40 (d), 124.85 (m), 24.70 (d, 
PCH(CH3)2), 20.45 (s, PCH(CH3)2), 20.29 (s, PCH(CH3)2), 19.75 (d, PCH(CH3)2). MS 
(m/z): calcd, 649.2784 [M+H]+; found, 649.2794 (FAB+, [M+H]+). 
 
Synthesis of 1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-dimethoxybenzene (1f) 
 
A Schlenk tube was charged with 1,4-di(2-bromophenyl)-2,3-di(methoxy)benzene 
(2.0449 g, 4.56 mmol), THF (30 mL), and a stir bar. The reaction mixture was cooled to -
78 °C with the use of a dry ice/acetone bath. Under a counter-flow of N2, a 1.7 M 
solution of tBuLi (11.0 mL, 18.7 mmol) in pentanes was added via syringe dropwise. A 
light yellow color appeared in seconds, and as the reaction was allowed to stir for 30 min 
at -78 °C, an orange color evolved. After stirring for 1 hour at -78 °C, 
chlorodiisopropylphosphine (1.55 mL, 9.74 mmol) was added to the reaction mixture via 
syringe under a counter-flow of N2, inducing a light yellow color. After stirring for 1h at -
78 °C, the reaction was removed from the dry ice/acetone bath and allowed to warm to 
room temperature. After stirring for 2 hours at room temperature the volatiles were 
removed under reduced pressure. Further manipulations were performed under an N2 
atmosphere in a wet glove box. The residue was treated with DCM (50 mL) and H2O (50 
mL) and transferred to a separatory funnel with vigorous mixing. The layers were 
P(iPr)2 (
iPr)2P
HO OH
(HO)2BAr
F
MgSO4
m-Xylenes, 120 °C
P(iPr)2 (
iPr)2P
O O
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ArF
(iPr)2PP(
iPr)2
OMeMeO
BrBr
OMeMeO
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separated and the aqueous washed with DCM (2 x 25 mL). The combined organics were 
dried with MgSO4, filtered, and concentrated under vacuum to an off-white powder. 
Trituration with MeOH (20 mL) afforded a white precipitate that was collected on a glass 
frit, and then dried under vacuum to yield the desired product in 60.3% (1.4385 g). 1H 
NMR (300 MHz, CDCl3), δ(ppm): 7.42 (m, 2 H, Ar-CH), 7.12 (m, 6 H, Ar-CH), 7.00 (s, 
2 H, Ar-C1H), 3.56 (s, 6 H, OCH3), 2.00 (m, 2 H, PCH(CH3)2), 1.79 (m, 2 H, PCH(CH3) 
2), 1.20 – 0.75 (m, 24H, PCH(CH3) 2). 31P{1H} (121 MHz, CDCl3), δ(ppm): -1.13 (s). 
13C{1H} (126 MHz, CDCl3), δ(ppm): 150.43 (s), 146.83 (d), 136.44 (m), 132.32 (s), 
130.77 (s), 127.97 (s), 126.55 (s), 125.77 (s), 60.12 (s), 25.22 (br), 24.41 (br), 20.0-19.0 
(m). MS (m/z): calcd, 523.2895 [M+H]+; found, 523.2891 (FAB+, [M+H]+). 
 
 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-catechol] 
tricarbonylmolybdenum(0) (2a) 
 
 
 
From 1a: Mo(CO)3(MeCN)3 (1.3010 g, 4.29 mmol) and 1a (1.0494 g, 2.12 mmol) were 
combined with THF (20 mL) and stirred at room temperature for 72 hours, generating a 
dark brown solution. Upon completion of the reaction (a single major peak near 50 ppm 
by 31P NMR), the volatiles were removed under reduced pressure and the residue then 
triturated with MeCN (15 mL). The resulting orange precipitate was collected on a glass 
frit and washed with minimal MeCN until the brown filtrate had lightened to pale orange. 
The remaining solid was then dried under vacuum to yield 0.6192 g (43.3%) of the 
desired product (spectroscopic features reported below). 
 
 
From 2b: In a wet glove box under N2, NaOMe (0.3380 g, 6.25 mmol) was added to a 
stirred suspension of 2b (1.5179 g, 2.08 mmol) in MeOH (15 mL) in a 100 mL round 
bottom flask, and the solution rapidly became homogeneous. After stirring for 1 hour at 
Mo(CO)3(NCMe)3
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room temperature, the volatiles were removed under reduced pressure. The residue was 
then treated with a saturated aqueous NH4Cl solution (50 mL) and DCM (50 mL) and 
transferred to a separatory funnel and thoroughly mixed. The layers were separated and 
the aqueous layer washed with DCM (2 x 25 mL). The combine organics were dried over 
MgSO4, filtered, and concentrated in vacuo. The resulting orange powder was transferred 
to a dry glove box and residual H2O/MeOH removed by triturating the powder in dry 
MeCN, collecting the solid on a glass frit, washing with additional dry MeCN, and finally 
drying under vacuum to yield 1.3072 g (93.3%) of the desired product. Crystals suitable 
for X-ray diffraction were grown from slow evaporation of a saturated C6H6 solution. 1H 
NMR (300 MHz, C6D6 , 25 °C), δ(ppm):  7.55 (m, 4 H, Ar-CH), 7.12 (m, 4 H, Ar-CH), 
5.73 (t, JPH = 4 Hz, 2 H, Ar-C1H), 5.26 (s, 2 H, Ar-C1OH),  2.66 (m, PCH(CH3)2), 2.54 
(m, PCH(CH3)2). 1.62 (m, 6H, PCH(CH3)2), 1.20 (m, 12H, PCH(CH3)2), 0.92 (m, 6 H, 
PCH(CH3)2). 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 50.62 (s). 13C NMR (125 
MHz, C6D6 , 75 °C), δ(ppm): 224.00 (t, Mo-CO), 214.23 (t, Mo-CO), 212.48 (t, Mo-CO), 
144.34 (t, Ar-C4), 141.67 (s, Ar-C3), 132.77 (t, Ar-C9), 131.96 (s, Ar-C5), 130.06 (s, Ar-
C8), 129.21 (s, Ar-C7), 127.65 (s, Ar-C2), 122.25 (t, Ar-C6), 87.58 (s, Ar-C1), 35.92 (t, 
PCH(CH3)2), 32.39 (t, PCH(CH3)2), 20.82 (m, PCH(CH3)2), 20.02 (s, PCH(CH3)2), 19.67 
(m, PCH(CH3)2), 19.57 (m, PCH(CH3)2). IR (DCM), νCO (cm-1): 1959.3, 1843.2 (br). λmax 
(THF, nm), ε (M-1cm-1): 478, 3.9x103; 355, 8.2x103; 285, 3.3x104. Anal. Calcd for [2a], 
C33H40MoO5P2: C, 58.76; H, 5.98. Found: C, 59.01; H, 5.72. 
 
 
Synthesis of [dimethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2b) 
 
Diphosphine 1b (2.204 g, 4.00 mmol) and (PhMe)Mo(CO)3 (1.314 g, 4.83 mmol) were 
combined in THF (10 mL) and added to a Schlenk tube charged with a stir bar and fitted 
with a screw-in Teflon stopper. The sealed vessel was removed from the glove box and 
heated to 70 °C with stirring in an oil bath for 3 hours. After complete conversion (a 
single peak at 52 ppm by 31P NMR), the Schlenk tube was returned to the glove box and 
the volatiles were removed under reduced pressure. The residue was triturated with 
MeCN (10 mL), and the resulting orange precipitate was collected on a glass frit, 
washing with minimal additional MeCN until the filtrate was a pale orange. The orange 
powder was then dried under vacuum to yield 2.7561 g (94.2%) of the desired product. 
Crystals suitable for X-ray diffraction were grown from cooling of a saturated MeCN 
solution at -35 °C. 1H NMR (300 MHz, C6D6 , 25 °C), δ(ppm): 7.92 (d, 2 H, Ar-CH), 
7.55 (d, 2 H, Ar-CH), 7.25 (t, 2 H, Ar-CH), 7.10 (t, 2 H, Ar-CH), 5.69 (t, JPH = 4 Hz, 2 H, 
Ar-C1H), 2.67 (m, PCH(CH3)2), 2.44 (m, PCH(CH3)2). 1.60 (m, 6H, PCH(CH3)2), 1.25 
(PhMe)Mo(CO)3
THF, 70 °C
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(m, 6H, PCH(CH3)2), 1.13 (m, 6H, PCH(CH3)2), 0.87 (m, 6 H, PCH(CH3)2), 0.58 (s, 3H, 
MeCN CH3) 0.08 (s, 3 H, SiCH3), -0.16 (s, 3 H, SiCH3). 31P NMR (121 MHz, C6D6 , 25 
°C), δ(ppm): 51.37 (s). 13C NMR (125 MHz, C6D6 , 25 °C), δ(ppm): 223.96 (t, Mo-CO), 
214.11 (t, Mo-CO), 212.85 (t, Mo-CO), 146.48 (s, Ar-C3), 144.58 (t, Ar-C4), 131.45 (t, 
Ar-C9), 131.27 (s, Ar-C5), 131.17 (t, Ar-C8), 128.73 (s, Ar-C7), 127.31 (t, Ar-C2), 120.99 
(t Ar-C6), 115.96 (s, MeCN NCCH3), 85.12 (s, Ar-C1), 35.66 (t, PCH(CH3)2), 32.39 (t, 
PCH(CH3)2), 20.57 (t, PCH(CH3)2), 19.67 (t, PCH(CH3)2), 19.60 (t, PCH(CH3)2), 19.40 
(m, PCH(CH3)2), 0.16 (s, MeCN NCCH3), -0.88 (s, SiCH3), -1.04 (s, SiCH3). IR 
(powder), νCO (cm-1): 1956, 1838, 1800 (br). IR (DCM), νCO (cm-1): 1959.3, 1843, 1835. 
Anal. Calcd for [2b•MeCN], C37H47MoNO5P2: C, 57.58; H, 6.24; N, 1.81. Found: C, 
57.25; H, 5.87; N, 1.80. 
 
 
Synthesis of [diethyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2c) 
 
 
Compound 2c was prepared analogously to 2b using diphosphine 1c (0.1577 g, 0.272 
mmol) and (PhMe)Mo(CO)3 (0.1120 g, 0.412 mmol) in THF (8 mL). The desired 
compound 2c was isolated as an orange powder in 79.2% yield (0.1638 g). 1H NMR (300 
MHz, C6D6 , 25 °C), δ(ppm): 8.01 (d, 2 H, Ar-CH), 7.60 (d, 2 H, Ar-CH), 7.30 (t, 2 H, 
Ar-CH), 7.14 (t, 2 H, Ar-CH), 5.78 (t, JPH = 4 Hz, 2 H, Ar-C1H), 2.72 (m, PCH(CH3)2), 
2.49 (m, PCH(CH3)2). 1.66 (m, 6H, PCH(CH3)2), 1.30 (m, 6H, PCH(CH3)2), 1.21 (m, 6H, 
PCH(CH3)2), 0.94 (m, 9 H, PCH(CH3)2 and SiCH2CH3), 0.62 (m, 5 H, SiCH2CH3 and 
SiCH2CH3). 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 51.47 (s). 13C NMR (125 MHz, 
C6D6 , 25 °C), δ(ppm): 223.92 (t, Mo-CO), 214.07 (t, Mo-CO), 212.59 (t, Mo-CO), 
146.84 (s, Ar-C3), 144.67 (t, Ar-C4), 131.56 (t, Ar-C9), 131.32 (s, Ar-C5), 131.14 (t, Ar-
C8), 128.76 (s, Ar-C7), 127.28 (t, Ar-C2), 120.97 (t, Ar-C6), 85.14 (s, Ar-C1), 35.65 (t, 
PCH(CH3)2), 31.38 (t, PCH(CH3)2), 20.59 (t, PCH(CH3)2), 19.68 (t, PCH(CH3)2), 19.56 
(t, PCH(CH3)2), 19.39 (m, PCH(CH3)2), 6.21 (s, SiCH2CH3), 5.92 (s, SiCH2CH3), 5.64 (s, 
SiCH2CH3), 5.05 (s, SiCH2CH3).  IR (film), νCO (cm-1): 1957, 1840, 1819. Anal. Calcd 
for [2c], C37H47MoO5P2Si: C, 58.57; H, 6.38. Found: C, 59.02; H, 6.51. 
 
 
 
 
 
(PhMe)Mo(CO)3
THF, 70 °C
P(iPr)2 (
iPr)2P
O O
Si
Et2
(iPr)2P P(
iPr)2
O O
Mo
OC
CO
OC
Si
Et2
1c 2c
	   	   S14 
Synthesis of [diisopropyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)silane]tricarbonylmolybdenum(0) (2d) 
 
 
Compound 2d was prepared analogously to 2b using diphosphine 1d (0.1829 g, 0.301 
mmol) and (PhMe)Mo(CO)3 (0.1260 g, 0.463 mmol) in THF (8 mL). The desired 
compound 2d was isolated as an orange powder in 78.5% yield (0.1862 g). 1H NMR (300 
MHz, C6D6 , 25 °C), δ(ppm): 8.03 (d, 2 H, Ar-CH), 7.59 (d, 2 H, Ar-CH), 7.29 (t, 2 H, 
Ar-CH), 7.12 (t, 2 H, Ar-CH), 5.79 (t, JPH = 4 Hz, Ar-C1H), 2.71 (m, PCH(CH3)2), 2.47 
(m, PCH(CH3)2). 1.66 (m, 6H, PCH(CH3)2), 1.30 (m, 6H, PCH(CH3)2), 1.21 (m, 6H, 
PCH(CH3)2), 1.07 (m, 6 H, SiCH(CH3)2), 0.93 (m, 8 H, PCH(CH3)2 and SiCH(CH3)2), 
0.79 (m, 6 H, SiCH(CH3)2. 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 51.69 (s). 13C 
NMR (125 MHz, C6D6 , 25 °C), δ(ppm): 223.84 (t, Mo-CO), 214.02 (t, Mo-CO), 212.30 
(t, Mo-CO), 146.92 (s, Ar-C3), 144.68 (t, Ar-C4), 131.66 (t, Ar-C9), 131.36 (s, Ar-C5), 
130.98 (t, Ar-C8), 128.82 (s, Ar-C7), 127.25 (t, Ar-C2), 120.76 (t, Ar-C6), 84.98 (s, Ar-
C1), 35.65 (t, PCH(CH3)2), 31.72 (t, PCH(CH3)2), 20.61 (t, PCH(CH3)2), 19.69 (t, 
PCH(CH3)2), 19.51 (t, PCH(CH3)2), 19.36 (m, PCH(CH3)2), 16.34 (s, SiCH(CH3)2), 15.85 
(s, SiCH(CH3)2), 13.45 (s, SiCH(CH3)2), 12.76 (s, SiCH(CH3)2).  IR (powder), νCO (cm-
1): 1953, 1836, 1812. Anal. Calcd for [2d], C39H52MoO5P2Si: C, 59.53; H, 6.66. Found: 
C, 59.22; H, 6.51. 
 
 
Synthesis of [4-(trifluoromethyl)phenyl-(1,4-bis(2-(diisopropylphosphino)phenyl)-
2,3-catechol)borane]tricarbonylmolybdenum(0) (2e) 
 
 
Compound 2e was prepared analogously to 2b using diphosphine 1e (0.4090 g, 0.631 
mmol) and (PhMe)Mo(CO)3 (0.2345 g, 0.862 mmol) in THF (10 mL). The desired 
compound 2e was isolated as a red powder in 76.6% yield (0.4010 g). 1H NMR (300 
MHz, C6D6 , 25 °C), δ(ppm): 7.96 (m, 2 H, Ar-CH), 7.69 (d, 2 H, BAr-CH), 7.62 (d, 2 H, 
(PhMe)Mo(CO)3
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Ar-CH), 7.41 (t, 2 H, Ar-CH), 7.23 (m, 4 H, BAr-CH and Ar-CH), 5.80 (t, JPH = 4 Hz, 2 
H, quinonoid Ar-CH),  2.73 (m, 2 H, PCH(CH3)2), 2.45 (m, 2 H, PCH(CH3)2). 1.63 (m, 
6H, PCH(CH3)2), 1.29 (m, 6 H, PCH(CH3)2), 1.10 (m, 6 H, PCH(CH3)2), 0.86 (m, 6 H, 
PCH(CH3)2). 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 51.49 (s).	  19F NMR (282 MHz, 
C6D6 , 25 °C), δ(ppm): -61.68 (s).  13C NMR (125 MHz, C6D6 , 25 °C), δ(ppm): 221.97 
(t, Mo-CO), 213.90 (t, Mo-CO), 213.15 (t, Mo-CO), 146.13 (s, Ar-C3), 143.08 (t, Ar-C4), 
135.89 (m, BAr-C), 134.00 (q, BAr-CF3), 131.58 (m, BAr-C), 131.21 (t, Ar-C9), 130.94 
(m, Ar-C5 and Ar-C8), 129. 28 (br, Ar-C7), 124.82 (t, Ar-C2), 121.80 (t, Ar-C6), 84.01 (s, 
Ar-C1), 35.54 (t, PCH(CH3)2), 31.70 (t, PCH(CH3)2), 20.35 (br, CH(CH3)2), 19.53 (br, 
PCH(CH3)2), 19.37 (br, PCH(CH3)2). IR (powder), νCO (cm-1): 1956, 1839 (br). Anal. 
Calcd for [2e] C40H42BF3MoO5P2: C, 57.99; H, 5.11. Found: C, 57.50; H, 5.14. 
 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
dimethoxybenzene]tricarbonylmolybdenum(0) (2f) 
 
Compound 2f was prepared analogously to 2b using diphosphine 1f (0.6007 g, 1.15 
mmol) and (PhMe)Mo(CO)3 (0.3988 g, 1.47 mmol) in THF (15 mL). The desired 
compound 2f was isolated as an orange powder in 78.7% yield (0.6354 g). 1H NMR (300 
MHz, C6D6 , 25 °C), δ(ppm): 7.78 (m, 2 H, Ar-CH), 7.54 (d, 2 H, Ar-CH), 7.24 (t, 2 H, 
Ar-CH), 7.16 (t, 2 H, Ar-CH), 5.81 (t, JPH = 4 Hz, 2 H, Ar-C1H), 2.64 (m, 2 H, 
PCH(CH3)2), 2.40 (m, 2 H, PCH(CH3)2). 1.68 (m, 6 H, PCH(CH3)2), 1.23 (m, 12 H, 
PCH(CH3)2), 0.91 (m, 6 H, PCH(CH3)2). 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 
50.09 (s). 13C NMR (125 MHz, C6D6 , 25 °C), δ(ppm): 222.76 (t, Mo-CO), 213.66 (t, 
Mo-CO), 213.62 (t, Mo-CO), 150.05 (s, Ar-C3), 145.13 (t, Ar-C4), 132.33 (t, Ar-C9), 
131.16 (s, Ar-C5), 131.05 (t, Ar-C8), 120.89 (t, Ar-C6), 128.67 (s, Ar-C7), 127.66 (t, Ar-
C2), 87.21 (s, Ar-C1), 60.53 (s, quinonoid Ar-OCH3), 36.42 (t, PCH(CH3)2), 33.08 (t, 
PCH(CH3)2), 21.26 (t, PCH(CH3)2), 20.04 (s, PCH(CH3)2), 19.59 (t, PCH(CH3)2), 19.47 
(t, PCH(CH3)2). IR (powder), νCO (cm-1): 1954, 1824 (br). Anal. Calcd for [2f], 
C35H44MoO5P2: C, 59.83; H, 6.31. Found: C, 60.12; H, 6.21. 
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THF, 70 °C
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Synthesis of [tetramethyl-1,3-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)disiloxane]tricarbonylmolybdenum(0) (2h) 
 
 
 
Compound 2a (0.0785 g, 0.116 mmol), (ClMe2Si)2O (0.0404 g, 0.199 mmol), and Et3N 
(0.0643 g, 0.635 mmol) were combined in THF (5 mL) and stirred for 12 hours at room 
temperature, developing a precipitate over this time. The mixture was then filtered 
through a pad of celite, washing with additional THF. The filtrate was then concentrated 
in vacuo and triturated with MeCN (5 mL). The resulting orange precipitate was collected 
on a pad of celite, dissolved in C6H6, filtered through celite, and concentrated under 
reduced pressure. The resulting residue is a mixture of 2h and 2b in ca. 8:1 ratio, 
respectively. Recrystallization twice via vapor diffusion of pentane into a saturated C6H6 
solution of the residue, collecting the filtrate, yields the desired compound (0.0187g, 
20.0%). 1H NMR (300 MHz, C6D6 , 25 °C), δ(ppm): 7.77 (d, 2 H, Ar-CH), 7.57 (d, 2 H, 
Ar-CH), 7.22 (t, 2 H, Ar-CH), 7.16 (m, 2 H, Ar-CH), 5.88 (t, JPH = 4 Hz, 2 H, Ar-C1H), 
2.67 (m, 2 H, PCH(CH3)2), 2.44 (m, 2 H, PCH(CH3)2). 1.66 (m, 6 H, PCH(CH3)2), 1.23 
(m, 12 H, PCH(CH3)2), 0.93 (m, 6H, PCH(CH3)2), 0.30 (s, 3 H, SiCH3), 0.05 (s, 3 H, 
SiCH3). 31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 50.05 (s). 13C NMR (121 MHz, 
C6D6 , 25 °C), δ(ppm): 223.83 (t, Mo-CO), 214.20 (t, Mo-CO), 213.02 (t, Mo-CO), 
145.64 (t, Ar-C4), 142.53 (s, Ar-C3), 132.24 (t, Ar-C9), 131.26 (s, Ar-C5), 130.89 (t, Ar-
C8), 127.23 (t, Ar-C2), 127.20 (t, Ar-C6), 87.50 (s, Ar-C1), 35.72 (t, PCH(CH3)2), 32.51 (t, 
PCH(CH3)2), 21.02 (t, PCH(CH3)2), 19.96 (s, PCH(CH3)2), 19.40 (t, PCH(CH3)2), -0.31 
(s, SiCH3), -0.47 (s, SiCH3). IR (powder), νCO (cm-1): 1956, 1838, 1800 (br). 
 
Synthesis of [tetraethyl-1,3-(1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
catechol)disiloxane]tricarbonylmolybdenum(0) (2i) 
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Compound 2a (0.1961 g, 0.291 mmol), (ClEt2Si)2O (0.0768 g, 0.296 mmol), and Et3N 
(0.1414 g, 1.40 mmol) were combined in THF (5 mL) and stirred for 12 hours at room 
temperature, developing a precipitate over this time. The mixture was then filtered 
through a pad of celite, washing with additional THF. The filtrate was then concentrated 
in vacuo and triturated with MeCN (5 mL). The resulting orange precipitate was collected 
on a pad of celite, dissolved in C6H6, filtered through celite, and concentrated under 
reduced pressure. The resulting residue is a mixture of 2i, 2c, and 2a in ca. 7:2:1 ratio, 
respectively. Recrystallization four times from hot pentane yields the desired compound 
(0.0165 g, 6.7%). 1H NMR (300 MHz, C6D6 , 25 °C), δ(ppm): 7.77 (d, 2 H, Ar-CH), 7.57 
(d, 2 H, Ar-CH), 7.24 (t, 2 H, Ar-CH), 7.16 (m, 2 H, Ar-CH), 5.88 (t, JPH = 4 Hz, 2 H, 
Ar-C1H), 2.68 (m, 2 H, PCH(CH3)2), 2.45 (m, 2 H, PCH(CH3)2). 1.67 (m, 6 H, 
PCH(CH3)2), 1.24 (m, 12 H, PCH(CH3)2), 1.12 (t, J3 = 8 Hz, 6 H, SiCH2CH3), 0.95 (m, 
6H, PCH(CH3)2), 0.77 (m, 10 H, SiCH2CH3 and SiCH2CH3), 0.57 (m, 4 H, SiCH2CH3). 
31P NMR (121 MHz, C6D6 , 25 °C), δ(ppm): 59.96 (s). 13C NMR (121 MHz, C6D6 , 25 
°C), δ(ppm): 223.88 (t, Mo-CO), 214.28 (t, Mo-CO), 212.80 (t, Mo-CO), 145.68 (t, Ar-
C4), 142.74 (s, Ar-C3), 132.30 (t, Ar-C9), 131.28 (d, Ar-C5), 131.13 (t, Ar-C8), 127.27 (m, 
Ar-C2), 127.21 (t, Ar-C6), 88.15 (s, Ar-C1), 35.73 (m, PCH(CH3)2), 32.52 (m, 
PCH(CH3)2), 21.07 (m, PCH(CH3)2), 19.95 (m, PCH(CH3)2), 19.59 (m, PCH(CH3)2), 
19.41 (m, PCH(CH3)2), 6.64 (s, SiCH2CH3), 6.49 (s, SiCH2CH3), 6.42 (s, SiCH2CH3), 
6.24 (s, SiCH2CH3). IR (film), νCO (cm-1): 1956, 1840, 1816. 
 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
quinone]dicarbonylmolybdenum(0) (3) 
 
A solution of 2a (0.0215 g, 0.0319 mmol) in THF (0.6 mL) was added to a J. Young style 
NMR tube and degassed via three freeze-pump-thaw cycles. An atmosphere of O2 was 
then added to the headspace and the tube inverted for 60 seconds. 31P NMR spectroscopy 
revealed complete conversion to a new species at approximately 72 ppm. The volatiles 
were removed under vacuum, and the residue was dissolved in MeCN (2 mL) and then 
the volatiles removed under vacuum, repeating this multiple times to remove the H2O 
side product. Finally, the residue was triturated with Hexanes and the volatiles removed 
under vacuum to afford the desired product in 96.4% yield (0.0198 g, 0.0307 mmol). 
Refluxing the compound in PhMe for an hour and then allowing the solution to cool to 
room temperature formed crystals suitable for X-ray diffraction. 1H NMR (300 MHz, 
CD3CN , 25 °C), δ(ppm): 7.43-7.68 (m, 8 H, Ar-CH), 5.09 (s, 2 H, C1H), 3.11 (m, 2 H, 
PCH(CH3)2). 2.93 (m, 2 H, PCH(CH3)2), 1.10-1.34 (m, 18 H, PCH(CH3)2), 0.82-0.92 (m, 
6 H, PCH(CH3)2). 31P NMR (121 MHz, CD3CN , 25 °C), δ(ppm): 72.43 (s). 13C NMR 
O2
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(126 MHz, CD3CN , 25 °C), δ(ppm): 246.34 (t, 20 Hz, Mo-CO), 222.58 (t, 18 Hz, Mo-
CO), 173.31 (s, quinonoid Ar-CO), 138.02 (m), 135.81 (m), 134.51 (s), 134.12 (s), 
132.62 (t), 132.10 (t), 130.02 (t), 100.58 (s, quinonoid Ar-CH), 65.30 (s, OCH3), 29.58 
(m, PCH(CH3)2), 28.98 (s, PCH(CH3)2), 19.03 (s, PCH(CH3)2), 18.30 (t, PCH(CH3)2), 
18.12 (s, PCH(CH3)2), 18.04 (s, PCH(CH3)2). IR (THF), νCO (cm-1): 1875, 1605. Anal. 
Calcd for [3], C32H38MoO4P2: C, 59.63; H, 5.94. Found: C, 60.11; H, 6.04. 
 
Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
dimethoxybenzene]dicarbonylmolybdenum(II) trifluoromethanesulfonate 
([52+][OTf-]2) 
 
To a stirred suspension of 2f (0.0400 g, 0.0569 mmol) in MeCN (2 mL) was added a 
solution of AgOTf (0.0331 g, 0.129 mmol) in MeCN (2 mL). Upon addition the reaction 
became a purple heterogeneous mixture, which was stirred at room temperature until the 
purple color dissipated (approximately 20 min), resulting in a yellow/brown 
heterogeneous mixture. The solution was then filtered through celite, and the filtrate was 
evaporated under reduced pressure. The resulting residue was freed of excess MeCN by 
trituration with hexanes (3 mL), followed by evaporation under reduced pressure to yield 
the desired product as a tan solid (0.0505 g, 91.2%). 1H NMR (300 MHz, CD3CN , 25 
°C), δ(ppm): 7.70-8.00 (m, 8 H, Ar-CH), 6.80 (s, 2 H, Ar-C1H), 3.42 (m, 2 H, 
PCH(CH3)2). 3.18 (m, 2 H, PCH(CH3)2), 1.35 (m, 18 H, PCH(CH3)2), 1.18 (m, 6 H, 
PCH(CH3)2). 31P NMR (121 MHz, CD3CN , 25 °C), δ(ppm): 72.43 (s). 19F NMR (282 
MHz, CD3CN , 25 °C), δ(ppm): -79.19 (s). 13C NMR (126 MHz, CD3CN , 25 °C), 
δ(ppm): 222.65 (t, Mo-CO), 222.58 (t, Mo-CO), 141.31 (s, quinonoid Ar-CO), 138.02 
(m), 135.81 (m), 134.51 (s), 134.12 (s), 132.62 (t), 132.10 (t), 130.02 (t), 100.58 (s, 
quinonoid Ar-CH), 65.30 (s, OCH3), 29.58 (m, PCH(CH3)2), 28.98 (s, PCH(CH3)2), 19.03 
(s, PCH(CH3)2), 18.30 (t, PCH(CH3)2), 18.12 (s, PCH(CH3)2), 18.04 (s, PCH(CH3)2). IR 
(MeCN), νCO (cm-1): 2019, 1961. λmax (MeCN, nm), ε (M-1cm-1): 430, 5.0x102; 350, 
2.0x103; 290, 6.4x103.	    Anal. Calcd for [52+][OTf-]2, C36H44F6MoO10P2S2: C, 44.45; H, 
4.56. Found: C, 44.23; H, 4.39. 
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Synthesis of [1,4-bis(2-(diisopropylphosphino)phenyl)-2,3-
methylsemiquinonate]dicarbonylmolybdenum(II) trifluoromethanesulfonate 
([6+][OTf-]) 
 
To a solution of 3 (0.0205 g, 0.0318 mmol) in MeCN (2 mL) was added MeOTf (5 µL, 
0.0442 mmol). The mixture was stirred for 5 minutes and the volatiles were removed 
under vacuum. The residue was triturated with C6H6 and the precipitate collected on a 
pad of celite, washing with additional C6H6. The solid was dissolved in MeCN, filtered 
through celite, and concentrated under reduced pressure. Excess MeCN was removed by 
triturating in hexanes followed by removal volatiles under vacuum. The desired 
compound was isolated as a pale yellow powder (0.0159 g, 0.0197 mmol, 61.8%). 1H 
NMR (300 MHz, CD3CN , 25 °C), δ(ppm): 7.60-7.80 (m, 8 H, Ar-CH), 5.89 (dd, JHP = 
5.7 Hz, 1.2 Hz, 1 H, Ar-C1H), 5.71 (dd, JHP = 5.7 Hz, 2.4 Hz, 1 H, Ar-C1H’), 3.92 (s, 3 H, 
OCH3), 3.41 (m, 2 H, PCH(CH3)2), 3.17 (m, 2 H, PCH(CH3)2), 1.20-1.45 (m, 18 H, 
PCH(CH3)2), 0.93-1.10 (m, 6 H, PCH(CH3)2). 31P NMR (121 MHz, CD3CN , 25 °C), 
δ(ppm): 78.19 (d, JPP’ = 18 Hz), 65.44 (d, JPP’ = 18 Hz). 19F NMR (282 MHz, CD3CN , 25 
°C), δ(ppm): -77.09 (s). 13C NMR (126 MHz, CD3CN , 25 °C), δ(ppm): 233.60 (dd, JCP = 
23.0 Hz, 21.5 Hz, Mo-CO), 228.62 (dd, JCP = 23.0 Hz, 21.5 Hz, Mo-CO), 163.51 (s, 
quinonoid Ar-C=O), 143.03 (d, Ar-C), 142.68 (d, Ar-C), 141.17 (d, Ar-C), 135.24 (m, 
O3S-CF3), 133.50 (m, Ar-C), 133.04 (m, Ar-C), 130.84 (m, Ar-C), 129.99 (m, Ar-C), 
129.28 (m, Ar-C), 128.06 (m, Ar-C), 124.13 (m, Ar-C), 123.31 (s, Ar-C), 120.76 (s, Ar-
C), 99.23 (m, quinonoid Ar-CH),  129.99 (m, Ar-C), 83.47 (m, quinonoid Ar-CH), 62.11 
(m, OCH3), 30.31 (s, PCH(CH3)2), 30.12 (s, PCH(CH3)2), 27.70 (m, PCH(CH3)2), 26.70 
(m, PCH(CH3)2), 18.46 (m, PCH(CH3)2), 18.46 (m, PCH(CH3)2), 18.04 (m, PCH(CH3)2), 
17.73 (m, PCH(CH3)2), 17.46 (m, PCH(CH3)2). IR (film), νCO (cm-1): 1979, 1907, 1615.  
 
 
Synthesis of bis(1,3-dimethylcyclopentadienyl)iron(II) (Me4Fc) 
 
 
 
 
MeCN, rt
[6+][OTf-]
OTf
(iPr)2P P(
iPr)2
MeO O
Mo
COOC
3    +    MeOTf 2
Me2CpLi  +  FeBr2
THF
70 °C
Me4Fc
C3
C2
C1
C4
Fe
	   	   S20 
In a schlenk tube, FeBr2 (1.0828 g, 5.02 mmol) and 1,3-dimethylcyclopentadienyl lithium 
(1.0438 g, 10.4 mmol) were combined in THF (30 mL) and heated to 70 °C for 3 hours, 
and the resulting brown/orange suspension was then concentrated under reduced 
pressure. The red-brown residue was extracted with Et2O (50 mL), filtered through 
alumina and concentrated under reduced pressure to yield the desired product as a red-
orange oil (0.4038 g, 33.2%). 1H NMR (300 MHz, C6D6, 25 °C), δ(ppm): 3.73 (s, 4 H), 
3.66 (s, 2 H), 1.86 (s, 12 H). 13C NMR (126 MHz, C6D6, 25 °C), δ(ppm): 83.17 (s, C2), 
71.86 (s, C1), 70.03 (s, C3), 14.34 (s, C4). ESI-MS (m/z, relative abundance): 242.2 [M]+, 
100%; 227.2 [M-CH3]+, 12%. MS (m/z): calcd, 242.0785 [M]+; found, 242.0764 (FAB+, 
[M]+). 
 
 
Control Reactions with O2 
 
  
1Br: An NMR solution of 1Br (0.0214 g, mmol) in CD2Cl2 (0.5 mL) prepared on the 
bench top was added to a J. Young style NMR tube and degassed via three freeze-pump-
thaw cycles. An atmosphere of O2 was added to the headspace and the reaction monitored 
by 1H NMR spectroscopy. There was no observed reaction over the course of 24 hours. 
 
 
 
2f: In the glove box, a solution of 2f (0.0198 g, mmol) in CD2Cl2 (0.6 mL) was added to a 
J. Young style NMR tube. On the Schlenk line, the solution was degassed via three 
freeze-pump-thaw cycles and an atmosphere of O2 was added to the headspace. The 
reaction was then monitored by 1H and 31P NMR spectroscopy. There was no observed 
reaction over the course of 24 hours. 
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2g: In the glove box, a solution of 2g (0.0225 g, mmol) in C6D6 (0.6 mL) was added to a 
J. Young style NMR tube. On the Schlenk line, the solution was degassed via three 
freeze-pump-thaw cycles and an atmosphere of O2 was added to the headspace. The 
reaction was then monitored by 1H and 31P NMR spectroscopy. There was no observed 
reaction over the course of 24 hours. 
 
Reactions with O2 
 
 
 
2b: A solution of 2b (0.0232 g, 0.0317 mmol) in CD2Cl2 (0.6 mL) in a J. Young style 
NMR tube was degassed via three freeze-pump-thaw cycles. An atmosphere of O2 was 
then added to the headspace, and the tube continuously inverted, monitoring the reaction 
over time by 1H and 31P NMR spectroscopy. After 1.5 hours at room temperature, the 
reaction exhibited a roughly 1:1:1 mixture of unconverted 2b, product 3, as well as an 
intermediate species identified as 2h (confirmed by independent synthesis, vida supra). 
After 3 hours the reaction had gone to completion with 2b fully converted to 3 and a 
mixture of Me2Si-containing products. An aliquant of the reaction mixture diluted in 
DCM was filtered through silica gel and submitted to gas chromatography-mass 
spectrometry (GC-MS) analysis, which revealed the Me2Si-containing products to be 
cyclooligomers of dimethylsiloxane (i.e. (Me2SiO)n where n = 3, 4, 5, 6). 
 
 
 
2c: The above procedure was repeated with 2c (0.0211 g, mmol) in CD2Cl2 (0.6 mL). 
After 8 hours at room temperature, 2c had converted to a 1:1 mixture of 3 and 2i. After 
48 hours at room temperature, 2i had fully converted to 3. 
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2d: The above procedure was repeated with 2d (0.0241 g, mmol) in CD2Cl2 (0.6 mL) and 
monitored by 1H and 31P NMR spectroscopy. After 5 days at room temperature, 3 had 
formed in ca. 15% along with ca. 35% unidentified species. 
 
 
 
2e: The above procedure was repeated with 2e (0.0201 g, 0.0243 mmol) in CD2Cl2 (0.6 
mL) and monitored by 1H, 19F, and 31P NMR spectroscopy. After 36 hours, 2e had 
converted to a mixture of species comprised mainly of 3 (ca. 80% relative integration by 
31P NMR) and other unidentified products. Additionally, the 19F NMR revealed two 
clusters of broad peaks grouped around -59.5 ppm and -61.5 ppm. 
 
To better understand the unidentified mixture of species, a solution of 3 (0.0202 g, 0.0313 
mmol) and (ArFBO)3 (0.0063 g, 0.0122 mmol, independently synthesized, ArF = p-
CF3C6H4)5 in CD2Cl2 (0.6 mL) was monitored by 1H, 19F, and 31P NMR spectroscopy. 
After one hour at room temperature, the mixture exhibited spectra that were qualitatively 
similar to the product of 2e with O2. Notably, by 31P NMR spectroscopy, broad peaks 
were observed ca. 1.5 ppm upfield of 3, with a relative ratio of 1:4 (unknown species : 3), 
and by 19F NMR, two sets of broad peaks were observed, grouped around -59.5 ppm and 
-61.5 ppm. Based on these results, it is plausible that in the reaction of 2e with O2 
“ArFB=O” or some other reactive B-O species may be transiently generated (analogous to 
Me2Si=O in reaction of 2b with O2), which could then react further by cyclization or 
oligomerization. The reaction of 3 with (ArFBO)3 suggests that 3 may form a Lewis acid-
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base adduct with (ArFBO)3, possibly prohibiting cyclization of “ArFBO” into the 
otherwise thermodynamic sink (ArFBO)3 and instead favoring higher oligomers. 
 
 
 
2f with B(C6F5)3: A solution of 2f (0.0210 g, 0.0299 mmol) and B(C6F5)3 (0.0301 g, 
0.0588 mmol) were combined in CD2Cl2 (0.6 mL) and added to a J. Young style NMR 
tube. The solution was degassed via three freeze-pump-thaw cycles and an atmosphere of 
O2 was added to the headspace. The reaction was followed by 1H, 19F, and 31P NMR 
spectroscopy. After 30 minutes the color of the solution had changed from orange to dark 
brown to deep purple with no signals observable by 31P NMR spectroscopy and only 
broad resonances observable by 1H NMR spectroscopy. After ca. 2 hours a large number 
of purple crystals had formed in the tube suitable for x-ray diffraction. If unperturbed, 
over the course of another 4-5 hours the purple color faded to yield a pale yellow solution 
with non-crystalline yellow precipitate. 31P and 1H NMR spectroscopy revealed two new 
diamagnetic products, a major symmetric species assigned as 52+ and a minor asymmetric 
species assigned as 6+. These assignments were confirmed by removal of the volatiles 
under vacuum and reconstituting the residue in CD3CN (0.6 mL) and comparing the 
NMR spectra to those of the independently synthesized [52+][OTf-]2 and [6+][OTf-].  
 
The above reaction with O2 was repeated with 2f (0.0221g, 0.0315 mmol) and B(C6F5)3 
(0.0332 g, 0.0648 mmol) in CD2Cl2 (0.6 mL). After approximately 24 hours, the volatiles 
were vacuum transferred to a second J. Young style NMR tube and the formation of Me-
2O was confirmed (δ = 3.27 ppm)6 in addition to small amounts of MeOH and H2O. The 
solution was then submitted to GC-MS and the Me2O eluted at 1.45 min with two major 
peaks at 45.1 and 46.1 m/z. 
 
The reaction was repeated as above with 2f (0.0197 g, 0.0280 mmol) and B(C6F5)3 
(0.0302 g, 0.0590) in CD2Cl2 (0.6 mL). Instead of natural abundance O2, 98% 18O2. After 
3 days, the volatiles were vacuum transferred to a second J. Young style NMR tube and 
the formation of Me2O confirmed. The solution was submitted to GC-MS, and the Me2O 
observed at 1.45 min with major peaks at 47.1 and 48.2 m/z consistent with Me218O, as 
well as minor peaks at 45.1 and 46.1 m/z consistent with Me216O. Relative ratio of 
18O/16O estimated at 3:1. 
 
(iPr)2P P(
iPr)2
MeO OMe
Mo0
OC
CO
OC
2 eq B(C6F5)3
O2 (1 atm)
rt, CD2Cl2
(iPr)2P P(
iPr)2
MeO OMe
MoII
COOC
2+ +
(iPr)2P P(
iPr)2
MeO O
Mo
COOC
2f 5
2+
6+
+
major
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+  Me2O
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2g with B(C6F5)3: A solution of 2g (0.0186 g, 0.0289 mmol) and B(C6F5)3 (0.0329 g, 
0.0643 mmol) were combined in CD2Cl2 (0.6 mL) and added to a J. Young style NMR 
tube. The solution was degassed via three freeze-pump-thaw cycles and an atmosphere of 
O2 was added to the headspace. The reaction was followed by 1H, 19F, and 31P NMR 
spectroscopy. After 45 minutes the color of the solution had changed from orange to dark 
brown to purple with loss of signal by 31P NMR spectroscopy and broadening of 
resonances by 1H NMR spectroscopy. By 19F NMR spectroscopy, generation of 
[((F5C6)3B)2O22-] can be observed. After 36 hours at room temperature, 31P and 1H NMR 
spectroscopy reveal formation of [P2Mo(CO)2]2+. 
 
 
 
2g with catechol: A solution of 2g (0.0203 g, 0.0315 mmol) and catechol (0.0073 g, 
0.0663 mmol) in CD2Cl2 (0.6 mL) in a J. Young style NMR tube was degassed via three 
freeze-pump-thaw cycles. An atmosphere of O2 was then added to the headspace, and the 
tube continuously inverted, monitoring the reaction over time by 1H and 31P NMR 
spectroscopy. Conversion of catechol was determined via 1H NMR integration using the 
residual PhMe from synthesis of 2g as internal standard. 
 
 
 
Me4Fc with catechol: A solution of Me4Fc (0.0106 g, 0.0438 mmol) and catechol (0.0107 
g, 0.0972 mmol) with diglyme (0.0022g, 0.0164 mmol) used as internal standard in 
CD2Cl2 (0.6 mL) in a J. Young style NMR tube was degassed via three freeze-pump-thaw 
cycles. An atmosphere of O2 was then added to the headspace, and the tube continuously 
inverted, monitoring the reaction over time by 1H and 31P NMR spectroscopy. After 3 
hours, the volatiles were removed under vacuum. The residue was diluted in THF (3 mL), 
and an aliquot (0.15 mL) was then further diluted with additional THF (2.85 mL, total 
(iPr)2P P(
iPr)2Mo
0
OC
CO
OC
2 eq B(C6F5)3
O2 (1 atm)
rt, CD2Cl2
(iPr)2P P(
iPr)2MoII
COOC
2g [P2Mo(CO)2
2+][{(F5C6)3B}2O2
2-]
B
O
O
B
ArF3
2-
ArF3
2+
O2 (1 atm)
3 hr rt, CD2Cl2
2g  +  2
OH
OH
< 15% conversion
OH
OH
O2 (1 atm)
3 hr, rt, CD2Cl2
Me4Fc  +  2
OH
OH
OH
OH
+  Me4Fc+
< 5% by
UV-Visno conversion
detectable by
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volume 3.0 mL). Quantification of Me4Fc oxidation was determined by UV-vis analysis 
of this diluted solution and comparison to a similarly diluted solution of Me4Fc (0.0106 g, 
0.0438 mmol) after oxidation with Ag(OTf) (0.0118 g, 0.0459 mmol) and filtering to 
remove the Ag0 precipitates. 
 
 
 
Reactions with H2O2 
 
 
 
2a: In a wet glove box under an N2 atmosphere, 2a (0.0213 g, 0.0316 mmol) in THF (2 
mL) was stirred in a 20 mL vial. An aqueous solution of H2O2 (3.3 M, 12 µL, 0.0396 
mmol) was added to the solution and the mixture stirred for 1 hour at room temperature. 
The volatiles were then removed under reduced pressure, and the residue was taken up in 
CD2Cl2 (0.6 mL) to reveal quantitative conversion from 2a to 3. 
 
 
 
3: As above, to a stirred solution of 3 (0.0198 g, 0.0307 mmol) and 1,3,5-
trimethoxybenzene (0.0039 g, 0.0315 mmol) in THF (2 mL) in a 20 mL vial was added 
an aqueous solution of H2O2 (3.3 M, 12 µL, 0.0396 mmol). The mixture was stirred for 1 
hour at room temperature. The volatiles were then removed under reduced pressure, and 
the residue was taken up in CD2Cl2 (0.6 mL) to reveal approximately 80% of 3 remained, 
along with approximately 20% conversion to unidentified species by 1H (relative 
integration of central arene C-H to internal standard trimethoxybenzene aryl C-H) and 31P 
(relative integration of peak at 71 ppm corresponding to 3 to group of signals at ca. 58 
ppm corresponding to unidentified species) NMR spectroscopy. 
 
Quantification of O2 consumed and CO released in conversion of 2a to 3 
In a Schlenk flask charged with a stir bar, 0.0504 g (0.0747 mmol) of 2a was dissolved in 
CHCl3 (12 mL). The solution was degassed by three freeze-pump-thaw cycles. The 
N2 (1 atm)
THF
2a 3
(iPr)2P P(
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OC
CO
OC
(iPr)2P P(
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O O
Mo
COOC
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3
(iPr)2P P(
iPr)2
O O
Mo
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+   H2O2
3
(iPr)2P P(
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O O
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reaction vessel was then exposed to 5.01 eq of O2 (0.377 mmol) via calibrated gas bulb 
and stirred vigorously for 5 hours at room temperature. After 5 hours the solution was 
frozen and the gas in the Schlenk flask was pumped through a liquid nitrogen cooled trap 
and collected in a calibrated volume (31.2 mL) using a Toepler pump. After 20 minutes 
(ca.  25 cycles of the Toepler pump) the Schlenk flask was sealed and thawed. Upon 
thawing the solution was re-frozen and the aforementioned Toepler pump process was 
repeated. After three of the described freeze-Toepler pump-thaw cycles, the pressure of 
gas collected was found to be 246.6 mm Hg (0.414 mmol, 5.51 eq after confirming 
quantitative conversion of 2a to 3 by 1H and 31P NMR spectroscopy). The gas was then 
exposed to a degassed solution of NaOH (0.75 g, 18.8 mmol) and pyrogallol (0.5 g, 3.96 
mmol) in H2O (20 mL) in a second Schlenk flask, and the solution was stirred vigorously 
for 4 hours to consume the excess O2. After 4 hours, the aqueous solution was frozen and 
the gas in the Schlenk flask was pumped through a liquid nitrogen cooled trap and 
collected in a calibrated bulb (31.2 mL) using three of the aforementioned freeze-Toepler 
pump-thaw cycles and the pressure of gas measured. Using the Toepler pump, the gas 
was then pumped through a CuO filled tube. The tube was heated and kept between 300 
and 350 °C. After 1 hour of pumping the gas through the CuO tube, the pressure of gas 
was again measured. By subtracting the two measurements, the total pressure of gas 
consumed in the CuO tube was found to be 47.5 mm Hg (0.0797 mmol, 1.06 eq). 
Performing the experiment described above in triplicate, it was found that reaction of 3 
with approximately 5 equivalents of O2 generated 0.48 ± 0.02 equivalents of gas, and the 
amount of non-O2 gas consumed in the CuO tube was found to be 1.05 ± 0.05. This data 
is consistent with a stoichiometry of 2a consuming 0.5 equivalents of O2 and releasing 1 
equivalent of CO.  
 
To further support this stoichiometry and confirm the identity of the gas being released in 
the reaction as CO, the Toepler pump experiment was repeated as mentioned above using 
0.0492 g (0.0729 mmol) of 2a with the following modification: after consuming the 
excess O2 in the NaOH/pyrogallol solution (rather than burning the gas in the CuO tube) 
the remaining gas was exposed to a solution of HN(pic)2 (0.0524 g, 0.263 mmol) and 
Cu(MeCN)4OTf (0.0954 g, 0.253 mmol) in MeCN (12 mL) and the mixture stirred 
vigorously for 4 hours. After 4 hours the gas remaining was measured, and the total gas 
consumed by the CuI solution was found to be 0.98 eq. IR data of the resulting CuI 
solution revealed a band at 2091 cm-1 consistent with formation of the previously 
reported HNpic2Cu(CO)BArF20,7 and identical to the band observed by independently 
exposing a mixture of Cu(MeCN)4OTf and HN(pic)2 to excess CO in MeCN. 
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II. Nuclear Magnetic Resonance Spectra 
 
 
Figure S1. 1H NMR spectrum of 1a in CDCl3 at 25 °C.	  
 
 
Figure S2. 13C{1H} NMR spectrum of 1a in CDCl3 at 25 °C.	  
 
 
Figure S3. 31P{1H} NMR spectrum of 1a in CDCl3 at 25 °C. 
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Figure S4. 1H NMR spectrum of 1b in C6D6 at 25 °C.	  
 
 
Figure S5. 13C{1H} NMR spectrum of 1b in C6D6 at 25 °C.	  
 
 
Figure S6. 31P{1H} NMR spectrum of 1b in C6D6 at 25 °C. 
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Figure S7. 1H NMR spectrum of 1c in CDCl3 at 25 °C.	  
 
 
Figure S8. 13C{1H} NMR spectrum of 1c in CDCl3 at 25 °C.	  
 
 
Figure S9. 31P{1H} NMR spectrum of 1c in CDCl3 at 25 °C. 
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Figure S10. 1H NMR spectrum of 1d in CDCl3 at 25 °C.	  
 
 
Figure S11. 13C{1H} NMR spectrum of 1d in CDCl3 at 25 °C.	  
 
 
Figure S12. 31P{1H} NMR spectrum of 1d in CDCl3 at 25 °C. 
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Figure S13. 1H NMR spectrum of 1e in C6D6 at 25 °C.	  
 
 
Figure S14. 13C{1H} NMR spectrum of 1e in C6D6 at 25 °C.	  
 
 
Figure S15. 31P{1H} NMR spectrum of 1e in C6D6 at 25 °C. 
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Figure S16. 19F NMR spectrum of 1e in C6D6 at 25 °C. 
 
Figure S17. 1H NMR spectrum of 1f in CDCl3 at 25 °C.	  
 
 
 
Figure S18. 13C{1H} NMR spectrum of 1f in CDCl3 at 25 °C.	  
 
 
	
	






		













	







	




	

	

	

		





	






























	


	



	   	   S33 
 
Figure S19. 31P{1H} NMR spectrum of 1f in CDCl3 at 25 °C. 
 
 
 
Figure S20. 1H NMR spectrum of 2a in C6D6. 
 
 
 
Figure S21. 13C{1H} NMR spectrum of 2a in C6D6 at 75 °C. 
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Figure S22. 31P{1H} NMR spectrum of 2a in C6D6. 
 
 
Figure S23. 1H NMR spectrum of 2b in C6D6 at 25 °C. 
 
 
 
Figure S24. 13C{1H} NMR spectrum of 2b in C6D6 at 25 °C. 
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Figure S25. 31P{1H} NMR spectrum of 2b in C6D6 at 25 °C. 
 
 
 
Figure S26. 1H NMR spectrum of 2c in C6D6 at 25 °C. 
 
 
Figure S27. 13C{1H} NMR spectrum of 2c in C6D6 at 25 °C.	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Figure S28. 31P{1H} NMR spectrum of 2c in C6D6 at 25 °C. 
 
 
Figure S29. 1H NMR spectrum of 2d in C6D6 at 25 °C.	  
 
 
Figure S30. 13C{1H} NMR spectrum of 2d in C6D6 at 25 °C.	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Figure S31. 31P{1H} NMR spectrum of 2d in C6D6 at 25 °C. 
 
 
Figure S32. 1H NMR spectrum of 2e in C6D6 at 25 °C.	  
 
 
Figure S33. 13C{1H} NMR spectrum of 2e in C6D6 at 25 °C. 
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Figure S34. 31P{1H} NMR spectrum of 2e in C6D6 at 25 °C. 
 
 
Figure S35. 19F NMR spectrum of 2e in C6D6 at 25 °C. 
 
 
Figure S36. 1H NMR spectrum of 2f in C6D6 at 25 °C.	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   S39 
Figure S37. 13C{1H} NMR spectrum of 2f in C6D6 at 25 °C. Solvent peaks off scale.	  
 
 
Figure S38. 31P{1H} NMR spectrum of 2f in C6D6 at 25 °C. 
 
 
Figure S39. 1H NMR spectrum of 2h in C6D6 at 25 °C.	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   S40 
Figure S40. 13C{1H} NMR spectrum of 2h in C6D6 at 25 °C. Solvent peaks off scale	  
 
 
Figure S41. 31P{1H} NMR spectrum of 2h in C6D6 at 25 °C. 
 
 
Figure S42. 1H NMR spectrum of 2i in C6D6 at 25 °C.	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   S41 
Figure S43. 13C{1H} NMR spectrum of 2i in C6D6 at 25 °C. Solvent peaks off scale	  
 
 
Figure S44. 31P{1H} NMR spectrum of 2i in C6D6 at 25 °C. 
 
 
Figure S45. 1H NMR spectrum of 3 in CD3CN at 25 °C.	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   S42 
Figure S46. 13C{1H} NMR spectrum of 3 in CD3CN at 25 °C. Solvent peaks off scale.	  
 
 
Figure S47. 31P{1H} NMR spectrum of 3 in CD3CN at 25 °C. 
 
 
Figure S48. 1H NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C.	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Figure S49. 13C{1H} NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C.	  
 
 
Figure S50. 31P{1H} NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C. 
 
 
Figure S51. 19F NMR spectrum of [52+][OTf-]2 in CD3CN at 25 °C. 
 
 
	
	


	


	


	






	


	



	





	

















	

	






	



	
	


	


	
	





	   	   S44 
Figure S52. 1H NMR spectrum of [6+][OTf-] in CD3CN at 25 °C.	  
 
 
Figure S53. 13C{1H} NMR spectrum of [6+][OTf-] in CD3CN at 25 °C.	  
 
 
Figure S54. 31P{1H} NMR spectrum of [6+][OTf-] in CD3CN at 25 °C. 
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   S45 
Figure S55. 19F NMR spectrum of [6+][OTf-] in CD3CN at 25 °C. 
 
 
 
Figure S56. 1H NMR spectrum of Me4Fc in C6D6 at 25 °C. 
 
 
 
Figure S57. 13C{1H} NMR spectrum of Me4Fc in C6D6 at 25 °C. 
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Figure S58. 1H NMR spectrum of 1Bra in CD2Cl2 under O2 at 25 °C after 10 minutes 
(bottom) and 24 hours (top). Solvent peak off scale. 
 
 
 
Figure S59. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2g in C6D6 under 
O2 at 25 °C after 10 minutes (bottom) and 24 hours (top). Solvent peak off scale. 
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Figure S60. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2f in CD2Cl2 
under O2 at 25 °C after 10 minutes (bottom) and 24 hours (top). 
 
 
 
Figure S61. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2a + H2O2 after 1 
hour (bottom) and 3 + H2O2 after 1 hour (top) in CD2Cl2 at 25 °C. 
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Figure S62. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2b under N2 
(bottom) and under O2 after 1.5 hours (middle) and after 3 hours (top) in CD2Cl2 at 25 
°C. 
 
 
 
Figure S63. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2c under O2 for 8 
hours (bottom) and 48 hours (top) in CD2Cl2 at 25 °C. 
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Figure S64. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2d under O2 for 
10 minutes (bottom) and 5 days (top) in CD2Cl2 at 25 °C. 
 
 
 
Figure S65. 19F NMR spectra (left), 1H NMR spectra (center) and 31P{1H} NMR spectra 
(right) of 2e under O2 after 10 minutes (bottom), 6 hours (middle), and 36 hours (top) in 
CD2Cl2 at 25 °C.  
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Figure S66. 19F NMR spectra (left), 1H NMR spectra (center) and 31P{1H} NMR spectra 
(right) of 2e under O2 (bottom) and 3 + (pCF3C6H4BO)3 under N2 (top) in CD2Cl2 at 25 
°C. 
 
Figure S67. 19F NMR spectra (left), 1H NMR spectra (center) and 31P{1H} NMR spectra 
(right) of 2f and 2 equivalents B(C6F5)3 under N2 (maroon), under O2 for 10 minutes 
(green), 7 hours (teal), and 24 hours (purple) in CD2Cl2 at 25 °C. 
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Figure S68. 19F NMR spectra (left), 1H NMR spectra (center) and 31P{1H} NMR spectra 
(right) of 2g and 2 equivalents B(C6F5)3 under N2 (maroon), under O2 for 15 minutes 
(green), 12 hours (teal), and 36 hours (purple) in CD2Cl2 at 25 °C. 
 
 
 
Figure S69. 1H NMR spectra (left) and 31P{1H} NMR spectra (right) of 2g and catechol 
under N2 (maroon), under O2 for 10 minutes (green), 3 hours (teal), and 36 hours (purple) 
in CD2Cl2 at 25 °C. 
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Figure S70. 1H NMR spectra of Me4Fc and catechol under N2 (maroon), under O2 for 10 
minutes (green), 90 minutes (teal), and 3 hours (purple) in CD2Cl2 at 25 °C. 
  
					



	   	   S53 
III. Ultraviolet-Visible Spectroscopy 
 
Figure S71. Reaction of 2e with 2 AgOTf in THF. The red trace represents the first data 
point after mixing. New band with λmax = 575 nm assigned to intermediate [4+][OTf-]. 
Traces taken every 30 seconds. After 20 minutes all of the major bands have diminished, 
consistent with formation of [52+][OTf-]2. (Note: traces shifted up ca. 0.3 a.u. with respect 
to baseline due to formation of Ag0 precipitate). 
 
 
Figure S72. Reaction of 2e and B(C6F5)3 with O2 in DCM. The red trace represents the 
first data point 30 seconds after mixing. Over time (red arrow), a new band with λmax = 
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575 nm assigned to [4+]2[{(F5C6)3B}2O22-]2 increases to a maximum at approximately 60 
minutes (blue trace), and diminishes again (blue arrow) over the course of another 600 
minutes (green trace). Over the course of the reaction, the bands with λmax = 390 nm and 
480 nm corresponding to 2e have been halved, consistent with a 2e:B(C6F5)3 
stoichiometry of 1:2. (Note: time between traces varies) 
 
IV. Cyclic Voltammetry 
 
 
Figure S73. Cyclic voltammograms of compounds 2b, 2d, 2e, 2f , 2g, and Me4Fc taken 
in 0.1 M [nBu4N+][PF6-] in THF with a glassy carbon working electrode at 250 mV/s. 
Potentials reported with respect to the Cp2Fe/Cp2Fe+ couple.  
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V. Crystallographic Information 
 
CCDC 1026539-1026542 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif.  
 
Refinement Details  
In each case, crystals were mounted on a glass fiber or nylon loop using Paratone oil, 
then placed on the diffractometer under a nitrogen stream. Low temperature (100 K) X-
ray data were obtained on a Bruker APEXII CCD based diffractometer (Mo sealed X-ray 
tube, Kα = 0.71073 Å) or a Bruker PHOTON100 CMOS based diffractometer (Mo micro-
focus sealed X-ray tube, Kα = 0.71073 Å). All diffractometer manipulations, including 
data collection, integration, and scaling were carried out using the Bruker APEXII 
software.8 Absorption corrections were applied using SADABS.9 Space groups were 
determined on the basis of systematic absences and intensity statistics and the structures 
were solved by direct methods using XS10, by intrinsic phasing using XT (incorporated 
into SHELXTL), or by charge flipping using Olex211 and refined by full-matrix least 
squares on F2. All non-hydrogen atoms were refined using anisotropic displacement 
parameters. Hydrogen atoms were placed in the idealized positions and refined using a 
riding model. The structure was refined (weighed least squares refinement on F2) to 
convergence. Graphical representation of structures with 50% probability thermal 
ellipsoids was generated using Diamond visualization software.12 
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Table 1. Crystal and refinement data for 2a•2.25C6H6, 2b•NCMe, 3, and  [4+]2[[(F5C6)3B]2O22-]•2CH2Cl2. 
Compound 2a•2.25C6H6 2b•NCMe 3 [4+]2[[(F5C6)3B]2O22-]•2CH2Cl2 
CCDC 1026539 1026540 1026541 1026542 
empirical formula C93H107Mo2O10P4 C37H47MoNO5P2Si C32H38MoO4P2 C108H92B2Cl4F30Mo2O12P4 
formula wt 1700.55 771.73 644.50 g/mol 2631.00 g/mol 
T (K) 100 100 100 100 
a, Å 11.9691(7) 11.4020(4) 11.6649(8) 12.511(1) 
b, Å 16.935(1) 17.1733(7) 16.1870(8) 15.145(1) 
c, Å 22.841(1) 19.0484(7) 16.4201(8) 15.613(1) 
α, deg 106.621(3) 90 90 64.704(3) 
β, deg 91.522(3) 102.399(1) 108.193(3) 81.599(3) 
γ, deg 109.707(3) 90 90 85.342(3) 
V, Å3 4137.5(4) 3642.9(2) 2945.4(3) 2645.5(4) 
Z 2 4 4 1 
cryst syst Triclinic Monoclinic Monoclinic Triclinic 
space group P-1 P21/c P21/c P-1 
dcalc, g/cm3 1.365 1.407 1.453 1.651 
θ range, deg 1.84-30.00 2.18-33.14 2.27-37.78 1.45-27.48 
µ , mm-1 0.440 0.523 0.590 0.514 
abs cor Semi-empirical Semi-empirical Semi-empirical Semi-empirical 
GOF 1.633 0.990 0.830 0.901 
R1a, wR2b (I > 2sig(I)) 0.0506, 0.2015 0.0486, 0.1523 0.0356, 0.1189 0.0576, 0.1453 
Diffractometer APEXII PHOTON100 APEXII APEXII 
a R1 = Σ||Fo| - |Fc||/Σ|Fo|. b wR2 = [Σ[w(Fo2 – Fc2)2]/ Σ[w(Fo2)2]]1/2
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Figure S74. Structural drawing of 2a with 50% probability ellipsoids. Hydrogen atoms 
and solvent molecules are omitted for clarity. Carbon atoms are shown in black. 
 
 
 
Figure S75. Structural drawing of 2b with 50% probability ellipsoids. Hydrogen atoms 
and solvent molecules are omitted for clarity. Carbon atoms are shown in black. 
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Figure S76. Structural drawing of 3 with 50% probability ellipsoids. Hydrogen atoms 
and solvent molecules are omitted for clarity. Carbon atoms are shown in black. 
 
 
Figure S77. Structural drawing of [4+]2[[(F5C6)3B]2O22-] with 50% probability ellipsoids. 
Hydrogen atoms, solvent molecules, and second Mo compound are omitted for clarity. 
Carbon and fluorine atoms are shown in black and green, respectively. 
 
Special Refinement Details for 4+: A ligand isopropyl group and the DCM solvent 
molecule were positionally disordered. Both were satisfactorily modeled as 
approximately 50:50 mixtures using “PART” cards in SHELX 
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